Trials / Conditions / Gastrointestinal Cancers

Gastrointestinal Cancers

30 registered clinical trials studyying Gastrointestinal Cancers — 12 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Clinical Evaluation of AI Decision Support for Early Rehabilitation After Surgery NCT07406269	Erasmus Medical Center	N/A
Not Yet Recruiting	Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma NCT07529808	BigHat Biosciences, Inc.	Phase 1 / Phase 2
Not Yet Recruiting	A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors NCT07173244	Tianjin First Central Hospital	—
Active Not Recruiting	Impact of Glycemic Variability on People With Gastrointestinal Cancer and Diabetes After Surgery NCT07180251	National Taiwan University Hospital	N/A
Recruiting	Predictive Value of Preoperative Rectus and Diaphragm Muscle Thickness for Postoperative Complications in Gast NCT07098871	Ankara Oncology Research and Training Hospital	—
Recruiting	Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detec NCT07039526	John Waters	Phase 2
Completed	Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology NCT06955468	Abramson Cancer Center at Penn Medicine	N/A
Recruiting	Prophylactic or Preemptive Entecavir in Patients With Gastrointestinal Cancer Who Are Inactive Hepatitis B Car NCT06966232	Sun Yat-sen University	Phase 3
Recruiting	Feasibility Study of CBCT for IGRT in Cancer Patients NCT06681233	Varian, a Siemens Healthineers Company	N/A
Recruiting	Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery NCT06731998	Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)	N/A
Recruiting	Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated H NCT06602167	Affiliated Hospital of Qinghai University	N/A
Recruiting	Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors NCT06908629	Barbara Ann Karmanos Cancer Institute	N/A
Withdrawn	Electronic Patient Reported Outcomes in Patients With Gastrointestinal Cancers NCT05359042	University of California, San Francisco	N/A
Terminated	Ketamine-assisted Therapy for Advanced GI Cancer NCT06077487	Brian Anderson, MD	Phase 4
Recruiting	Personalized Health Self-Management Training for Colorectal Cancer Survivors NCT05984589	University of Southern California	N/A
Completed	Frailty Scales for Predicting Chemotherapy Toxicity in Older Adults With Gastrointestinal Cancers NCT07184047	Ankara Etlik City Hospital	—
Completed	Predicting Chemotherapy Toxicity Using FRAIL and FIND in Older Adults With Gastrointestinal Cancers NCT07272538	Ankara Etlik City Hospital	—
Completed	Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers NCT05641896	SOFIE	Phase 2
Completed	DPD Guided 5-FU Precision Treatment in Gastro-intestinal Cancer Patients NCT06782022	Jan Gerard Maring	Phase 2
Recruiting	PRecision Oncology CUhk pRogrammE (PRO-CURE) NCT04724070	Brigette Ma	—
Terminated	Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research an NCT03407040	National Cancer Institute (NCI)	—
Completed	Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressin NCT02045368	IGF Oncology, LLC	Phase 1
Unknown	A Pilot Study of Genomic Sequencing Guided Individualized Therapy in Gastrointestinal Cancers, GITIC Study NCT02013089	Sun Yat-sen University	N/A
Terminated	A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Sel NCT02005614	Yale University	N/A
Completed	Bevacizumab as a Palliative Treatment for Patients With Symptomatic Malignant Ascites Due to Advanced-stage Ga NCT01200121	AIO-Studien-gGmbH	Phase 2
Completed	Sex Differences in Gastrointestinal Cancer Surgery NCT07017712	Medizinische Hochschule Brandenburg Theodor Fontane	—
Completed	Vitamin D for Chemoprevention NCT00585637	Dana-Farber Cancer Institute	Phase 1
Unknown	Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy NCT02349958	Bay Area Gynecology Oncology	Phase 2
Completed	Transitoriness in Cancer Patients, Psychosocial Issues in Cancer Care NCT00364078	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	—
Available	Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors NCT06872489	Second Life Therapeutics	—